DeutschNewstral
Article
jdsupra.com on 2016-06-17 03:32
OIG Recommends that CMS Require States to Use Claim Modifier on Medicaid Claims to Identify 340B Drug Claims
Related news
- GAO Recommends CMS, HRSA Improve 340B Duplicate Discount Oversightjdsupra.com
- OIG Recommends CMS Use OIG Hospital Compliance Audits to Enhance its Medicare Oversightjdsupra.com
- OIG Report Examines Potential Scenarios for Restructuring 340B Programjdsupra.com
- CMS Outpatient Advisory Panel Speaks Out Against Planned 340B Cutsjdsupra.com
- OIG Urges CMS to Change Medicare Infusion Drug Paymentsjdsupra.com
- OIG Claims CMS Paid $729 Million in Erroneous EHR Incentive Paymentsjdsupra.com
- OIG Estimates CMS Made $730 Million in Improper EHR Incentive Payments, Based on Small Sample of Claimsjdsupra.com
- CMS and OIG Issue Notice of Amended Waivers for Next Generation ACO Modeljdsupra.com
- CMS expands reimbursement cuts on 340B drugsjdsupra.com
- CMS restores 340B drug acquisition reimbursementjdsupra.com
- CMS Proposes Reimbursement Reduction for 340B Drugsjdsupra.com
- In Targeting Outlier Payment Reconciliation, OIG Calls for an Aggressive Reading of CMS Reopening Regulationsjdsupra.com
- CMS and OIG Issue Final ACO Waiversjdsupra.com
- OIG Recommends Improvements to Skilled Nursing Facility Billing Policies Regarding Changes in Therapyjdsupra.com
- HHS OIG to Review CMS Citationsjdsupra.com
- OIG Examines Medicare Part B Payments for 340B Purchased Drugsjdsupra.com
- OIG Recommends Reevaluation of Medicare Payment System for Skilled Nursing Facilitiesjdsupra.com
- CMS Finalizes 340b Payment Provisions in 2023 OPPS Final Rulejdsupra.com
- CMS Issues Final OPPS Rule, Slashing Reimbursement for 340B Drugsjdsupra.com
- CMS Sneaks 340B Billing Proposals into Medicare Physician Fee Schedule: What 340B Stakeholders Need to Knowjdsupra.com